Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
earnings
COVID-19
GLP-1 agonist
JNJ
Bristol Myers Squibb
Pfizer
AstraZeneca
Sanofi
Eli Lilly
Novo Nordisk
New weight-loss drugs linked to lower risk of depression: study
Axios
Fri, 02/9/24 - 11:12 am
depression
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
Motley Fool
Thu, 02/8/24 - 10:01 pm
Merck
Eli Lilly
Novo Nordisk
weight loss
Eli Lilly’s Verzenio fails prostate cancer test as possible Novartis showdown nears
Fierce Pharma
Wed, 02/7/24 - 11:26 am
Eli Lilly
Verzenio
prostate cancer
Eli Lilly settles Minnesota lawsuit over insulin pricing
Reuters
Wed, 02/7/24 - 11:19 am
Eli Lilly
legal
insulin
drug pricing
diabetes
Minnesota
Lilly expects strong 2024 profit on rising weight-loss drug demand
Reuters
Tue, 02/6/24 - 10:16 am
Eli Lilly
earnings
Zepbound
Mounjaro
Eli Lilly axes next-generation, resistance-busting RET inhibitor
Fierce Biotech
Tue, 02/6/24 - 10:14 am
Eli Lilly
LOXO-260
RET inhibitors
thyroid cancer
non-small cell lung cancer
Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains
Fierce Pharma
Tue, 02/6/24 - 09:33 am
Eli Lilly
tirzepatide
Novo Nordisk
Zepbound
Mounjaro
Could Novo, Lilly become first trillion-dollar healthcare companies?
Pharma Voice
Mon, 02/5/24 - 10:30 am
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
obesity
weight loss
FDA website shows limited availability of some doses of Lilly's Mounjaro
Reuters
Mon, 02/5/24 - 10:12 am
FDA
drug shortages
Eli Lilly
Mounjaro
Zuellig Pharma acquires Cialis and Alimta brands from Lilly
Pharmaceutical Business Review
Mon, 02/5/24 - 10:11 am
Eli Lilly
Zuellig Pharma
Cialis
Alimta
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?
Motley Fool
Fri, 02/2/24 - 11:50 am
Abbott Labs
Novo Nordisk
Eli Lilly
weight loss
Protality
Lilly's weight-loss drug Mounjaro coming to UK after pen cleared
Reuters
Thu, 01/25/24 - 09:00 pm
Eli Lilly
Mounjaro
UK
obesity
diabetes
Lilly's Mounjaro dose in limited availability in US through next month
Reuters
Wed, 01/24/24 - 11:39 pm
Eli Lilly
Mounjaro
drug shortages
Lilly makes waves, says gene therapy restores hearing for child with genetic hearing loss
Fierce Biotech
Tue, 01/23/24 - 06:04 pm
Eli Lilly
gene therapy
hearing loss
Akouos
AK-OTOF
Drugmakers explore muscle loss prevention when taking weight loss drugs
Beckers Hospital Review
Tue, 01/23/24 - 11:06 am
weight loss
muscle
Ozempic
Wegovy
Eli Lilly
Regeneron
United States of Ozempic: Where anti-obesity drugs are taking off
Axios
Fri, 01/19/24 - 09:31 am
Ozempic
Zepbound
Wegovy
Novo Nordisk
Eli Lilly
obesity
United States
Eli Lilly’s Jaypirca to dominate CLL BTK inhibitor market by 2032
Biopharma Reporter
Thu, 01/18/24 - 05:04 pm
Eli Lilly
Jaypirca
CLL
Btk inhibitors
Researchers probe new uses of popular weight loss, diabetes drugs
Beckers Hospital Review
Tue, 01/16/24 - 09:08 am
GLP-1 agonist
Ozempic
Mounjaro
Wegovy
Novo Nordisk
Eli Lilly
JPM2024: Lilly CEO David Ricks Weighs In on GLP-1s and AI
BioSpace
Mon, 01/15/24 - 09:43 am
JPMHC 2024
Eli Lilly
David Ricks
artificial intelligence
GLP-1 agonist
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »